Kyntra Bio (KYNB) EBT Margin Growth (5y) (2019 - 2026)
Kyntra Bio (KYNB) EBT Margin Growth (5y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Kyntra Bio | 30.42 Mn | 30.42 Mn | 1.47 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 136,454.00 |
| Mar 31, 2026 | 137,971.00 |
| Dec 31, 2025 | -105,443.00 |
| Sep 30, 2025 | -129,722.00 |
| Jun 30, 2025 | 1,646.00 |
| Mar 31, 2025 | -29,017.00 |
| Dec 31, 2024 | 95,330.00 |
| Sep 30, 2024 | -3.91 Mn |
| Jun 30, 2024 | -1.19 Mn |
| Mar 31, 2024 | -203,864.00 |
| Dec 31, 2023 | 7,116.00 |
| Sep 30, 2023 | -1,380.00 |
| Jun 30, 2023 | -56,122.00 |
| Mar 31, 2023 | -442,517.00 |
| Dec 31, 2022 | -80,963.00 |
| Sep 30, 2022 | -52,414.00 |
| Jun 30, 2022 | -14,020.00 |
| Mar 31, 2022 | -54,330.00 |
| Dec 31, 2021 | -72,686.00 |
| Sep 30, 2021 | 11,149.00 |